A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption

Prost, Jean-Christophe; Brunner, Felix; Bovet, Cédric; Grob, Christian; Berchtold, Christian; Schlotterbeck, Götz; Kröll, Dino; Largiadèr, Carlo Rodolfo; Fiedler, Georg Martin; Juillerat, Pascal (2017). A UHPLC–MS/MS method for the quantification of 7α-hydroxy-4-cholesten-3-one to assist in diagnosis of bile acid malabsorption. Clinical mass spectrometry, 3, pp. 1-6. Elsevier 10.1016/j.clinms.2017.02.001

Text UHPLC.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (917kB)

Bile acids malabsorption (BAM) is encountered in numerous gastrointestinal pathologies and is a good
example of a treatable cause of watery diarrhea after ileal resection. The gold standard for diagnosing
BAM is the selenium homocholic acid taurine test (SeHCAT), an expensive and complex analysis. An alternative
method is the quantification of 7a-hydroxy-4-cholesten-3-one (C4). Here, we present a simple,
ultra high-performance liquid chromatography–tandem mass spectrometry method to measure C4 in
human serum. To avoid time consuming sample preparation (e.g., derivatization, solid phase extraction),
we used absorption chemistry-based extraction plates. This method demonstrates a lower limit of quantification
of 5 ng/mL and is linear over a concentration range from 5 to 300 ng/mL (R2 = 0.9977).
Inaccuracy and imprecision were less than 15%. The validated method is currently used for routine measurement
of C4 from serum in patients to confirm BAM diagnosis.

Interest & Impact

Downloads

4 since deposited on 09 Feb 2018
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item